Affinity DataKi: 2.70nMAssay Description:Inhibition constant against recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 5.80nMAssay Description:Inhibition constant against recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataKi: 366nMAssay Description:Inhibitory activity against recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 2.20nMAssay Description:Inhibitory activity against steroid 5-alpha-reductase type 2 in human prostate homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 2.30nMAssay Description:Inhibitory activity against Steroid 5-alpha-reductase type I in human scalp homogenatesMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 4nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 7.60nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 8nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 8.5nMAssay Description:Inhibition of recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 14.4nMAssay Description:Inhibition of recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
Affinity DataIC50: 15.6nMAssay Description:Inhibition of recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 15.8nMAssay Description:Inhibition of recombinant Steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 17nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 21nMAssay Description:Compound was tested for in vitro activity against s-phospholipase A2 (s-PLA2) isolated from human plateletsMore data for this Ligand-Target Pair
Affinity DataIC50: 23nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:Compound was tested for in vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and micellar substrate with deoxycholate (DOC)More data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 30nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 35nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 40nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibitory activity against Steroid 5-alpha-reductase type I in human scalp homogenatesMore data for this Ligand-Target Pair
Affinity DataIC50: 41nMAssay Description:Inhibitory activity against Steroid 5-alpha-reductase type I in human scalp homogenatesMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 49nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 50nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 60nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
Affinity DataIC50: 65nMAssay Description:Compound was tested for in vitro activity against s-phospholipase A2 (s-PLA2) isolated from human plateletsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 74nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by bilayer assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 80nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 95nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 120nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 120nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and micellar substrate with deoxycholate (DOC)More data for this Ligand-Target Pair
Affinity DataIC50: 137nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 141nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
TargetCytosolic phospholipase A2 beta(Homo sapiens (Human))
Astrazeneca R&D Charnwood
Curated by ChEMBL
Astrazeneca R&D Charnwood
Curated by ChEMBL
Affinity DataIC50: 150nMAssay Description:Inhibitory activity against cytosolic Phospholipase A2 (PLA2) by soluble assayMore data for this Ligand-Target Pair
Affinity DataIC50: 176nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 185nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 188nMAssay Description:Inhibition of recombinant steroid 5-alpha-reductase type I expressed in CHO cellsMore data for this Ligand-Target Pair
Affinity DataIC50: 190nMAssay Description:In vitro activity against porcine pancreatic phospholipase-A2 (PLA2) and monomerically dispersed substrateMore data for this Ligand-Target Pair